CD8A and infection: Tamoxifen showed immunomodulatory activity even in uninfected mice; on the day of treatment that would correspond to day eight post-infection, tamoxifen significantly decreased the percentage of CD8+ cells and significantly increased the CD16+/CD32+ cells (Figure 3C,F), respectively.